MedPanel

Views & Analysis

New survey data from MedPanel, compiled exclusively for pharmaphorum, has revealed US physicians’ thoughts on the topics set to dominate ASCO.

R&D

Where do doctors see patients with rare diseases, how do they keep up with treatment advances and what can pharmaceutical companies do to help?

News

Lilly's retatrutide achieved weight loss of more than 30% at two years in a new trial, firming up its credentials as a next-generation obesity drug.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.